BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12168839)

  • 41. Monoclonal antibody to human esophageal cancer endothelium inhibits angiogenesis and tumor growth.
    Zhang Y; Ran Y; Yu L; Hu H; Zhou Z; Sun L; Lou J; Yang Z
    Anticancer Res; 2006; 26(4B):2963-70. PubMed ID: 16886621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.
    Ohta K; Yamaguchi Y; Shimizu K; Miyahara E; Toge T
    Anticancer Res; 2002; 22(5):2597-606. PubMed ID: 12529970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
    Conforti A; Peruzzi D; Giannetti P; Biondo A; Ciliberto G; La Monica N; Aurisicchio L
    J Immunother; 2009 Sep; 32(7):744-54. PubMed ID: 19561534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen.
    Lu QJ; Bian GX; Chen YY; Zhang M; Guo SM; Wen LQ
    Acta Pharmacol Sin; 2005 Oct; 26(10):1259-64. PubMed ID: 16174444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.
    Date M; Fukuchi K; Namiki Y; Okumura A; Morita S; Takahashi H; Ohura K
    Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
    Aarts WM; Schlom J; Hodge JW
    Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies against CEA. Comparison of the immunoprecipitates by fingerprint analysis.
    Grunert F; Wank K; Luckenbach GA; Von Kleist S
    Oncodev Biol Med; 1982; 3(2-3):191-200. PubMed ID: 6181485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors.
    Tanaka T; Huang J; Hirai S; Kuroki M; Kuroki M; Watanabe N; Tomihara K; Kato K; Hamada H
    Clin Cancer Res; 2006 Jun; 12(12):3803-13. PubMed ID: 16778108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
    Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
    Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate.
    Hamblett KJ; Senter PD; Chace DF; Sun MM; Lenox J; Cerveny CG; Kissler KM; Bernhardt SX; Kopcha AK; Zabinski RF; Meyer DL; Francisco JA
    Clin Cancer Res; 2004 Oct; 10(20):7063-70. PubMed ID: 15501986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a transgenic mouse model for anti-human CEA radioimmunotherapeutics.
    Wilkinson RW; Ross EL; Ellison D; Zimmermann W; Snary D; Mather SJ
    J Nucl Med; 2002 Oct; 43(10):1368-76. PubMed ID: 12368376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice.
    Larbouret C; Robert B; Linard C; Teulon I; Gourgou S; Bibeau F; Martineau P; Santoro L; Pouget JP; Pelegrin A; Azria D
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1231-7. PubMed ID: 17967312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo.
    Biglari A; Southgate TD; Fairbairn LJ; Gilham DE
    Gene Ther; 2006 Apr; 13(7):602-10. PubMed ID: 16397508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting of T cells to CEA-expressing tumor cells by chimeric immune receptors with a highly specific single-chain anti-CEA activity.
    Arakawa F; Shibaguchi H; Xu Z; Kuroki M
    Anticancer Res; 2002; 22(6C):4285-9. PubMed ID: 12553071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
    Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
    Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and specificity of vindesine monoclonal anti-carcinoembryonic antigen conjugate with nine human cancer cell lines.
    Ford CH; Bartlett SE; Casson AG; Marsden CH; Gallant ME
    NCI Monogr; 1987; (3):107-16. PubMed ID: 3547144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Monoclonal antibody 9A3 raised against a human poorly differentiated gastric adenocarcinoma cell line].
    Ochiai A; Tahara E
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1416-22. PubMed ID: 3729460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.